Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Alphamab, Ascletis, Astrazeneca, Biophytis, Eli Lilly, Genassist, H. Lundbeck, Hefei Tianhui, Innovent, Lianbio, Novavax, Oramed, Otsuka, Radiopharm, Specialized.